The BIG-big-bankers are still upset and it has to do with Yale and BigPharma.

The BIG-big-bankers are still upset and it has to do with Yale and BigPharma.

To: jmcgowan@nih.gov, zerhoune@od.nih.gov, SpinLyme@yahoogroups . com ,
kshepard@calea.org, fitzmas@gmail . com , patrick.fitzgerald@usdoj.gov,
modelt1918@sbcglobal . net , jdrazen@nejm.org, letters@courant . com ,
Jgerberding@cdc.gov, lender@courant . com , michael.cole@po.state.ct.us,
conndcj@po.state.ct.us, executive-editor@nytimes . com , managing-
editor@nytimes . com , news-tips@nytimes . com , the-arts@nytimes . com ,
bizday@nytimes . com , foreign@nytimes . com , metro@nytimes . com ,
national@nytimes . com , dvbid@cdc.gov, brigidcallahan@optonline . net ,
trvl@hotmail . com , ubinas@courant . com , mas1@concentric . net ,
campbell@courant . com , jhornberger@fff.org, thomas.carson@usdoj.gov,
thomas.ryan@po.state.ct.us, kurtzh@washpost . com ,
georgewill@washpost . com , horgan@courant . com ,
commissioner.dcf@po.state.ct.us, cohencolumn@aol . com ,
FalNields@aol . com , bransfield@comcast . net , vtsherr@comcast . net ,
oca@po.state.ct.us, dand@davila-dilzer . com ,
scott.murphy@po.state.ct.us, governor.rell@po.state.ct.us,
attorney.general@po.state.ct.us, randall.samborn@usdoj.gov
Cc: francam@ucia.gov, dr-ahmadinejad@president.ir,
eugenerobinson@washpost . com , horgan@courant . com ,
bmiller@newstimes . com , trvl@hotmail . com , rastro18@aol . com ,
billcurryct@gmail . com , thomas.carson@usdoj.gov, amcguigan@rms-law . com ,
rjmurzyn@aol . com , paulcraigroberts@yahoo . com ,
sidney blumenthal@yahoo . com , criminal.division@usdoj.gov,
karla.dobinski@usdoj.gov, christopher.christie@usdoj.gov

Subject: [SpinLyme] The BIG-big-bankers are still upset and it has to
do with Yale and BigPharma.

Date: Apr 12, 2008 8:19 AM

The BIG-big-bankers are still upset and it has to do with Yale,
vaccines, and BigPharma.
They keep their money on offshore establishments, which they
themselves don't
investigate (the IMF/CFR), because, they claim, "insurance companies
are a
very small part of the offshoring."

They happen to be the bulk of it.
For instance, the AIG-CFR Greenbergs- the very people whose butts were
being pursued
by Spitzer.


They apparently don't appreciate the news that there is the other,
unspoken
end of the NIAID spread (vaccines damage due to immune incompetence)
and they don't
appreciate all the facts on my website about psychiatry and
psychotropics.

Anthony Fauci is a liar and he is Edward McSweegan's boss:
* w w w .actionlyme.org/The Fauci Files.htm
He lied to the American public on the CNN Lou Dobbs show about the
LYMErix vaccine.
It was not "scientifically proven." It was never a vaccine according
to FDA's rules for the validation of an analytical method, and a bogus
method
was used to qualify it. That bogus Dearborn method only allows the
INFLAMMATORY
kind of Lyme to be detected, proving that NIAID exists in
contradiction to the evidence
of immune deficiency diseases, especially fungal diseases:
* w w w .actionlyme.org/BIOWEAPONEERS CORIXA YALE TLRS.htm
* w w w .actionlyme.org/CDCS PARTICIPATION IN LYME CRIMES.htm

They also do not like all the 9/11 news, especially that the UN will
now investigate
the Neocons' role in that stunt. Don't forget, Levin, the president
of
Yale was involved in the 9/11 Commission's hilarious excuse for an
investigation:
* w w w .actionlyme.org/CHENEYMO PSYCHOANALYSIS.htm
* w w w .actionlyme.org/911 HOAX.htm
* w w w .actionlyme.org/070426hometemp.htm




Kathleen M. Dickson
* w w w .actionlyme.org


-----Original Message-----
>From: Kathleen <janmusinski@earthlink . net >
>Sent: Apr 11, 2008 5:41 AM


>Subject: [SpinLyme] COURANT: Drug companies' disclosure and Baxter's
new OspA vaccine
>
>COURANT ARTICLE BELOW IS INCOMPLETE
>=========================================
>
>Um, Lyme cabal members Gary Wormser and Allen Steere are paid consultants for
Baxter who wants to produce a new tripartite OspA vaccine, when do to
so, clearly
shows intent to continue to define Lyme as an autoimmune arthritis in
a knee, when
in 33 years, Allen Steere has yet to prove Lyme is an autoimmune
arthritis in a
knee. In fact, NINDS' Roland Martin went back to Germany because he
was unable
to prove the Multiple Sclerosis kind of Lyme (does not test positive,
since "CDC
positive" is the Steere genetically linked OspA hypersensitivity
reaction in
a knee), was an autoimmune T cell disease.
>
>Steere not proving "Lyme disease" is an autoimmune arthritic disease:
> * w w w .ncbi.nlm.nih.gov/pubmed/18191206?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed ResultsPanel.Pubmed RVDocSum
>Martin not proving the former, pre-Dearborn kind of Lyme, is an autoimmune neurologic
disease:
> * w w w .ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=(martin+r%5BAuthor%5D+OR+martin+r%5BInvestigator%5D)+AND+(%22borrelia%22%5BMeSH+Terms%5D+OR+Borrelia%5BText+Word%5D)
>Steere and Wormser consulting for Baxter:
> * w w w .actionlyme.org/WORMSER INSISTS LYME A KNEE DISEASE.htm
>NIH's Edward McSweegan declaring that a new OspA vaccine would be easier
to promote in Europe because Europeans are stupider than Americans:
> * w w w .actionlyme.org/MCSWEEGAN AND DUMB EUROPEANS.html
>What happened at Dearborn:
> * w w w .actionlyme.org/CRYMEDISEASE CHP3.htm
>(includes the CDC's final announcement with no bands OspA and B (31 and
34 kilodaltons apparent weight)
>Who Approved of this bogus standard despite none of the invited labs agreeing:
> * w w w .actionlyme.org/Dearborn Who Approved.htm
>(McSweegan, Alan Barbour, and Allen Steere)
>My explanation to the FDA vaccine committee that there was an older CDC standard
for the diagnosis of Lyme that treated it as a Relapsing Fever
organism, and that
no one among the invited labs agreed with the cabal:
> * w w w .actionlyme.org/DICKSON FDA SUBMISSION FULL.htm
>
>The RICO complaint which makes the whole thing simpler and something you can
see with your own eyeballs (darker bands means higher antibody
concentration consistent
with a hypersensitivity reaction, and not aberrant T cells, as Steere
proposes):
> * w w w .actionlyme.org/USDOJ COMPLAINT RICO.htm
>Steere's HLA:
> * w w w .ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=steere+AC%5BAuthor%5D+AND+HLA%5BAll+Fields%5D
>
>I'll say it again, "Lyme Disease" - the new and bogus definition
that happened at Dearborn in order to falsely qualify LYMErix - is a
hypersensitivity
reaction or a condition of kinetics, where the antigen fits too
tightly in the Steere
HLA molecule and causes a toxic "complex."
>
>It does not mean no infection and it does not mean infection, but as we know
with other allergies, they go away when not exposed to the antigen any
more (seasonal
allergies).
>
>IF, over time, autoimmune arthritis in a knee subsides, that could be due to
antigenic variation, and the bugs are no longer making the kind of
OspA that "binds
the HLA molecule."
>
>I would say it the other way around. The HLA molecule binds the antigen, rather
than simply presenting it, as I demonstrate in the second RICO video:
> * w w w .actionlyme.org/YOUTUBEVIDEOS.htm
>with "Mr. Panda."
>
>
>So, bottom line, Baxter is not listed here in this story and neither is SmithKline.
The Lyme cabal at New York Medical College and Yale insist Lyme is an
"autoimmune
arthritis in a knee" and that "there is no such thing as the Roland
Martin,
National Institute of Neurological Disorders and Stroke kind of
Lyme." In
this way, these criminals can use the fact that the cabal invented
that there is
"no such thing as anything other than Lyme-as-a-bad-knee," because
they
are still being sued, after the two class actions against them.
>
>If chronic and latent Lyme was the real disease we say it is - by re-reporting
these crooks' own data - then it is something that could be activated
by the
immune suppressing qualities of OspA, which is a fungal antigen and
known to be
immune suppressing:
> * w w w .actionlyme.org/BIOWEAPONEERS CORIXA YALE TLRS.htm
>
>Here is proof that Yale et al know fungal antigens cause immune suppression:
> * w w w .pubmedcentral.nih.gov/picrender.fcgi?artid=1407827&blobtype=pdf
>
>We're saying "Chronic Lyme" is the chronic infection that causes
immune suppression diseases related outcomes, like the exacerbation of
latent viral
infections (causing MS), Lou Gehrig's Disease, Lupus, Chronic Fatigue
Syndrome,
and the ver-certain dementia like syphilis, as proven by these
criminals themselves,
but also, independent dental researchers:
> * w w w .actionlyme.org/LYME IS A PERMANENT BRAIN INFECTION.htm
>
>
>You can call the NIH and verify the Yale Lyme crooks' assertion that Roland
Martin does not exist.... because he went back to Germany and you'd
have to
call there to talk to him about the MS kind of Lyme, or else view his
reports linked
from the right nav bar of my website, which I acquired by being "an
irresponsible
parent," by "going to the Yale Medical Library."
> * w w w .actionlyme.org/Hilarious.htm
>
>My sister, Nancy Martin, who is a genuine pinhead, does not like the fact that
I am a scientist, because my father was an engineer. Don't expect
that to make
any sense, since we are talking about the "logic" that comes from a
very
small cranium. True Microencephaly.
>
>Kathleen M. Dickson
>
>==================================================
>courant . com /news/nationworld/ats-ap top13apr11,0,2546973.story
>Courant . com
>Drug Companies to Reveal Grant Practices
>
>By KEVIN FREKING
>
>Associated Press Writer
>
>3:15 AM EDT, April 11, 2008
>
>WASHINGTON
>
>For years, the nation's largest drug and medical device manufacturers have
courted doctors with consulting fees, free trips to exotic locales and
by sponsoring
the educational conferences that physicians attend.
>
>Those financial ties don't have to be disclosed in most cases and can lead
to arrangements that some say improperly influence medical care.
>
>Now, under the threat of regulation from Congress, the two industries promise
to be more forthcoming about their spending. A dozen of the nation's
leading
drug and device makers have told Sen. Charles Grassley, R-Iowa, that
they have plans
or are working on plans to publicly disclose grants to outside groups.
The details
will be provided on each company's Web sites.
>
>Watchdog groups say the companies are trying to head off legislation that would
require public disclosure of their giving.
>
>"If they were doing this out of the goodness of their heart, they would
have done so decades ago," said Dr. Peter Lurie of the consumer group
Public
Citizen.
>
>Of particular interest to Grassley is the money that companies spend on continuing
medical education. Physicians go to such conferences to fulfill their
license requirements
and to keep up to date with the latest treatment trends. Professional
associations
and companies frequently ask drug and device makers to help pay for
the conferences.
Recently, Grassley asked 15 companies whether they planned to follow
the lead of
Eli Lilly & Co., which now discloses its grants to such programs.
>
>"If your company does not yet have any efforts or plans in place, please
explain why not," Grassley wrote.
>
>The responses are in. They are wide-ranging, but mostly what the senator wanted
to hear. Indeed, many of the companies said they would go beyond
disclosing grants
for medical education. Some companies said they would also disclose
payments to
patient advocacy groups such as the American Heart Association or the
American Diabetes
Association. Boston Scientific said it was developing a system that
even discloses
certain payments to physicians.
>
>Medtronic Inc. said it will post payments for professional meetings and patient
groups on its Web site beginning May 1. AstraZeneca PLC said it would
do the same
on Aug. 1, providing the amount spent and the purpose of the
financing. AstraZeneca
gets between 4,000 and 5,000 grant applications each year and funds
about a third
of them.
>
>Merck and Co. was vague about its plans, but committed to the concept. "We
are currently in the process of developing an action plan," the
company wrote
to Grassley.
>
>Amgen Corp. and Abbott Laboratories said they had formed working groups to determine
how to compile and display their grants.
>
>Shering-Plough Corp., however, told the senator what he didn't want to hear:
"We do not publish or have plans at the moment to publish a list of
charitable
contributions or educational grants that medical organizations have
received from
us."
>
>Grassley said, overall, he was happy with the responses.
>
>"The way these companies are making information about financial relationships
open to scrutiny is the right thing to do," he said.
>
>Two other companies said they already were disclosing third-party payments.
The two, Zimmer Inc. and Stryker Orthopedics Inc., avoided criminal
prosecution
over financial inducements paid to surgeons to use their products,
prosecutors announced
last year. The companies agreed to new corporate compliance procedures
and federal
monitoring. Zimmer also had to pay the government $169.5 million.
>
>The hip-and-knee industry was the subject of a recent Senate Aging Committee
hearing titled "Surgeons for Sale." Companies routinely paid doctors
$5,000
every three months for providing information on market trends and
operating-room
activity. However, the reports typically offered only cursory
descriptions and often
were duplicated from one quarter to the next. Also, companies
sponsored consultant
meetings at resort locations. The meetings lasted just a few hours
each day. The
physicians who presented information at the meetings spoke for as
little as 10 minutes.
>
>"Although the remainder of the day was available for recreational activities
paid for by the company, the consultants were compensated $5,000 for a
full day
of work," said Gregory E. Demske, an assistant inspector general.
>
>Eli Lilly began listing its grants last year. It gave $18.9 million in the second
quarter of 2007, according to the Prescription Policy Project, a
Boston-based group
that promotes policies to reduce conflicts of interest.
>
>"They support those organizations which they believe will have a positive
impact on their drug sales," said David Rothman of Columbia University
and
associate director of the Prescription Policy Project. "It's self-
evident
but important."
>
>If all of the companies follow through with their commitments to Grassley, there
also would be widespread disclosure of how much money they give
patient advocacy
groups. The groups rely on industry for much of their financing. For
example, the
American Heart Association said donations from the pharmaceutical and
device industry
make up about 6 percent of its annual income, and totaled $48.3
million in the organization's
latest fiscal year.
>
>"Donations from corporations, including the pharmaceutical and device industry,
allow us to further enhance our programs and outreach, and to bring
objective science
and the highest quality of public education and information to more
people,"
said Maggie Francis, the association's communications manager.
>
>Grassley and Sen. Herb Kohl, D-Wis., have introduced legislation that would
require drug and device makers to disclose anything of value given to
physicians,
such as payments, gifts or travel.
>
>The disclosure of medical education grants is an extension of that concept.
Last year, the staff for the Senate Finance Committee issued a report
that said
the drug industry may be using the "medical education industry to
deliver favorable
messages about off-label uses that the drug companies cannot legally
deliver on
their own."
>
>The committee report noted that Warner-Lambert, now owned by Pfizer Inc., paid
$430 million to settle claims that medical conferences it sponsored
were used to
ill